Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / email-mfn-pricing-analysis.eml
email-mfn-pricing-analysis.eml
Parties
Penterra Pharmaceuticals Corp
Firth LLP
Hong Kong SA
Macau SA
Harkness LLP
Dates
August 4, 2023
August 28, 2023
Amounts
$150
$150,000
$750,000
Obligations
Sublicensee Compliance / Flow-Down** The MFN pricing obligation must flow down to all sublicensees
The Term Sheet provides that Meridian may grant sublicenses with Penterra's prior written consent (not to be unreasonably withheld), and each sublicense must contain terms no less protective of Penterra's rights, including the MFN pricing clause